AE Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.71M Buy
20,600
+1,141
+6% +$94.6K 0.01% 568
2025
Q1
$1.58M Sell
19,459
-40
-0.2% -$3.24K 0.01% 587
2024
Q4
$1.76M Buy
19,499
+8,083
+71% +$728K 0.01% 566
2024
Q3
$1.13M Buy
11,416
+232
+2% +$22.9K 0.01% 669
2024
Q2
$1.04M Buy
11,184
+1,314
+13% +$122K 0.01% 689
2024
Q1
$937K Sell
9,870
-10,905
-52% -$1.03M 0.01% 663
2023
Q4
$1.83M Buy
20,775
+1,374
+7% +$121K 0.01% 934
2023
Q3
$1.42M Sell
19,401
-1,664
-8% -$122K 0.01% 961
2023
Q2
$1.75M Buy
21,065
+4,697
+29% +$391K 0.01% 883
2023
Q1
$1.25M Sell
16,368
-50,457
-76% -$3.85M 0.01% 961
2022
Q4
$5.55M Buy
66,825
+55,976
+516% +$4.65M 0.04% 452
2022
Q3
$861K Buy
10,849
+3,748
+53% +$297K 0.01% 1002
2022
Q2
$527K Buy
7,101
+4,070
+134% +$302K ﹤0.01% 1174
2022
Q1
$272K Sell
3,031
-3,274
-52% -$294K ﹤0.01% 1455
2021
Q4
$706K Sell
6,305
-233
-4% -$26.1K ﹤0.01% 1106
2021
Q3
$822K Sell
6,538
-556
-8% -$69.9K 0.01% 933
2021
Q2
$960K Buy
7,094
+383
+6% +$51.8K 0.01% 857
2021
Q1
$910K Sell
6,711
-402
-6% -$54.5K 0.01% 802
2020
Q4
$1M Buy
7,113
+905
+15% +$127K 0.01% 708
2020
Q3
$692K Sell
6,208
-965
-13% -$108K 0.01% 744
2020
Q2
$803K Buy
7,173
+2,012
+39% +$225K 0.01% 694
2020
Q1
$400K Buy
5,161
+2,023
+64% +$157K 0.01% 754
2019
Q4
$298K Sell
3,138
-606
-16% -$57.5K 0.01% 901
2019
Q3
$286K Sell
3,744
-2,112
-36% -$161K 0.01% 804
2019
Q2
$514K Buy
5,856
+1,295
+28% +$114K 0.02% 582
2019
Q1
$413K Buy
4,561
+1,294
+40% +$117K 0.03% 387
2018
Q4
$234K Sell
3,267
-2,100
-39% -$150K 0.04% 404
2018
Q3
$515K Buy
5,367
+2,033
+61% +$195K 0.03% 311
2018
Q2
$317K Buy
3,334
+522
+19% +$49.6K 0.02% 319
2018
Q1
$247K Buy
+2,812
New +$247K 0.02% 364
2017
Q4
Sell
-3,539
Closed -$306K 465
2017
Q3
$306K Buy
3,539
+687
+24% +$59.4K 0.03% 304
2017
Q2
$220K Buy
+2,852
New +$220K 0.03% 340